跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 67 条关于
“Sinaptica”
全部
67
临床试验
46
药物
2
机构
4
资讯
15
去年
NeuroTherapia and Sinaptica Advance Alzheimer's Therapies into Phase 2 Trials
去年
Sinaptica Therapeutics' rTMS Shows Promise in Slowing Alzheimer's Progression in Phase 2 Trial
去年
Sinaptica's Neuromodulation Device Shows Promise in Phase II Alzheimer's Trial
去年
Sinaptica's Neuromodulation Device Shows Promise in Phase II Alzheimer's Trial
去年
Personalized rTMS Shows Promise in Slowing Alzheimer's Progression in Phase 2 Trial
去年
Transcranial Magnetic Stimulation Shows Promise in Slowing Alzheimer's Symptoms
去年
Personalized Neuromodulation Slows Alzheimer's Progression in Phase 2 Trial
去年
Semaglutide Shows Promise for Osteoarthritis, Ozempic and Wegovy Availability Improves
去年
Alzheimer's Drug Pipeline Shows Promising Diversity as 88 Trials Recruit Patients in 2025
去年
Spinogenix Targets Synaptic Regeneration with Small Molecule Drugs for Neurological Diseases
第 1 页,共 2 页
上一页
下一页